2,958
Views
19
CrossRef citations to date
0
Altmetric
Coronaviruses

Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study

, , , , , , ORCID Icon, , , , & show all
Pages 2680-2688 | Received 02 Aug 2022, Accepted 04 Oct 2022, Published online: 04 Nov 2022

References

  • WHO. WHO coronavirus disease (COVID-19) dashboard.
  • Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022 Apr;22(4):e102–e107.
  • Shah W, Hillman T, Playford ED, et al. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. Br Med J. 2021 Jan 22;372(n136).
  • Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Network Open. 2021 Oct 1;4(10):e2128568.
  • Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021 Aug 28;398(10302):747–758.
  • Zhou F, Tao M, Shang L, et al. Assessment of sequelae of COVID-19 nearly 1 year after diagnosis. Front Med (Lausanne). 2021;8:717194.
  • Petersen EL, Gossling A, Adam G, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg city health study COVID programme. Eur Heart J. 2022 Mar 14;43(11):1124–1137.
  • Seessle J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): A prospective cohort study. Clin Infect Dis. 2022 Apr 9;74(7):1191–1198.
  • Rivera-Izquierdo M, Lainez-Ramos-Bossini AJ, de Alba IG, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes – a multicentre cohort study. BMC Med. 2022 Feb 23;20(1):92.
  • Liu T, Wu D, Yan W, et al. Twelve-Month systemic consequences of coronavirus disease 2019 (COVID-19) in patients discharged from hospital: A prospective cohort study in Wuhan, China. Clin Infecti Dis. 2022 Jun 10;74(11):1953–1965.
  • Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. The Lancet Resp Med. 2022 May 11;10(9):863–876.
  • National Health Commission of the People's Republic of China. (2020 Feb 6). Handbook of prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV) (in Chinese). [Accessed Jul 2, 2020]. http://en.nhc.gov.cn/2020-02/06/c_76295.htm.
  • National Health Commission of the People's Republic of China. (2020 Mar 16). Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment. [Accessed July 2, 2020]. http://kjfy.meetingchina.org/msite/news/show/cn/3337.html
  • Pan F, Ye T, Sun P, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020 Jun;295(3):715–721.
  • Francone M, Iafrate F, Masci GM, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020 Dec;30(12):6808–6817.
  • Brightling CE, Evans RA. Long COVID: which symptoms can be attributed to SARS-CoV-2 infection? Lancet. 2022 Aug 6;400(10350):411–413.
  • Finsterer J, Scorza FA, Scorza CA, et al. SARS-CoV-2 impairs vision. J Neuro-Ophthalmol. 2021 Jun 1;41(2):166–169.
  • Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022 Jan;22(1):43–55.
  • Antonelli M, Pujol JC, Spector TD, et al. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022 Jun 18;399(10343):2263–2264.
  • Chen Y, Ding C, Yu L, et al. One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection. BMC Med. 2021 Aug 9;19(1):191.
  • Han X, Fan Y, Alwalid O, et al. Fibrotic interstitial lung abnormalities at 1-year follow-up CT after severe COVID-19. Radiology. 2021 Dec;301(3):E438–E440.
  • Pan F, Yang L, Liang B, et al. Chest CT patterns from diagnosis to 1 year of follow-up in patients with COVID-19. Radiology. 2022 Mar;302(3):709–719.
  • Luger AK, Sonnweber T, Gruber L, et al. Chest CT of lung injury 1 year after COVID-19 pneumonia: The CovILD study. Radiology. 2022 Mar 29;304(2):462–470.
  • Eberst G, Claude F, Laurent L, et al. Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia. Ann Intensive Care. 2022 Mar 9;12(1):23.
  • Vijayakumar B, Tonkin J, Devaraj A, et al. CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge. Radiology. 2022 May;303(2):444–454.
  • Bocchino M, Lieto R, Romano F, et al. Chest CT-based assessment of 1-year outcomes after moderate COVID-19 pneumonia. Radiology. 2022 May 10;220019.
  • Ravaglia C, Doglioni C, Chilosi M, et al. Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J. 2022 Oct 6;60(4):2102411.
  • Guler SA, Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021 Apr 29;57(4):2003690.
  • van Gassel RJJ, Bels JLM, Raafs A, et al. High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19. Am J Respir Crit Care Med. 2021 Feb 1;203(3):371–374.
  • Caruso D, Guido G, Zerunian M, et al. Post-Acute sequelae of COVID-19 pneumonia: Six-month chest CT follow-up. Radiology. 2021 Nov;301(2):E396–E405.
  • Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601–615.
  • Costa GMJ, Lacerda SMSN, Figueiredo AFA, et al. SARS-CoV-2 infects, replicates, elevates angiotensin II and activates immune cells in human testes. medRxiv. 2022.
  • Bowe B, Xie Y, Xu E, et al. Kidney outcomes in long COVID. J Am Soc Nephrol. 2021 Nov;32(11):2851–2862.
  • Liao X, Li D, Ma Z, et al. 12-Month Post-Discharge liver function test abnormalities Among patients With COVID-19: A single-center prospective cohort study. Front Cell Infect Microbiol. 2022;12:864933.
  • Brodin P, Casari G, Townsend L, et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022 May;28(5):879–882.
  • Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022 Mar 3;185(5):881–895.e20.
  • Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. 2022 Apr;604(7907):697–707.
  • Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. The Lancet Resp Med. 2021 Nov;9(11):1275–1287.
  • Liu YH, Chen Y, Wang QH, et al. One-Year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study. JAMA Neurol. 2022 May 1;79(5):509–517.
  • Ballering AV, van Zon SKR, Olde Hartman TC, et al. Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet. 2022 Aug 6;400(10350):452–461.